Navin Fluorine International update upcoming cGMP-4 facility at Dewas
Navin Fluorine International announced that Phase 1 of cGMP-4 with a capital expenditure of ~ Rs. 160 crore has achieved commissioning readiness today with validation batches having commenced for the company's European partner. The aforesaid refers to the capital expenditure of Rs. 288 crore for new cGMP-4 facility at Dewas.

TIPCO Engineering India Ltd IPO Allotment Status Online
4 mins read . Mar 24, 2026

Powerica Ltd IPO Allotment Status Online
4 mins read . Mar 20, 2026

Sai Parenteral's Ltd IPO Allotment Status Online
4 mins read . Mar 20, 2026
